First-in-class isogenic model of the human neurovascular unit offers unparalleled human relevance for studying blood-brain barrier drug transport and neuroinflammation. Emulate, Inc., the leading ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Emulate, Inc. today announced that it recently formed a research collaboration with Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration's (FDA) newly announced plan to reduce reliance on animal testing in ...
Drug-induced liver injury (DILI) is a leading cause of safety-related clinical trial failures and market withdrawals around the world. 1–3 While it has plagued drug development for decades, physicians ...
Emulate, the developer of chips that simulate the physiology of human and animal tissues and organs, has signed a multiyear cooperative R&D agreement with the U.S. FDA’s Office of Foods & Veterinary ...
Emulate, Inc., the leading provider of next-generation Organ-on-a-Chip technology, in partnership with FUJIFILM Cellular Dynamics, Inc., a pioneering global developer and manufacturer of human induced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results